Make an Impact: Annual Meeting to Launch Strategic Plan Through 2020
The agenda is coming together for the MassBio Annual Meeting, being held April 3-4 at the Royal Sonesta Hotel in Cambridge. Program sessions will include discussions on rebuilding the industry’s reputation, mobile technologies and 3D printing, clinical trial design and the future of gene therapy.
The agenda also includes elections for the MassBio Board of Directors, two keynote speeches and the annual awards luncheon.
The meeting will kick off with the release of Impact 2020, a new strategic plan for the industry and MassBio. Based on nearly 100 stakeholder interviews, survey data and original research, the plan will assess the critical events, trends, policies and discoveries that will impact the life sciences sector through 2020. The report also makes recommendations to ensure that the industry thrives in Massachusetts and continues to advance science for generations to come.
A panel discussion on value in healthcare will analyze the implication for business leaders as the result of the changing landscape in hospital reimbursement, regulations and priorities. This will be a continuation of the conversation begun at MassBio’s 2014 Policy Leadership Breakfast.
Business track panels will discuss:
• New ways to fund your early-stage company
• What the life sciences industry needs to do to rebuild its reputation
• Winning strategies in business development and corporate development: what are they and how to from them
• Mobile technology and 3D printing: technologies gaining traction in biotech and pharma
• Evolving business relationships between biotech, pharma, investors, and academia Science track panels will discuss:
• Clinical trial design trends
• The second coming of gene therapy
• New approaches in the management of neurological disease
• Is there an industry opportunity cost to focusing on rare disease?
The MassBio Annual Meeting also includes the Innovative Leadership Award luncheon, which honors an industry leader for his or her contribution to moving the industry forward.
Registration is now open online at www.MassBio.org. Sponsorship opportunities are also available. Contact Elizabeth Steele at 617-674-5100 or email@example.com.
MassBio’s Economic Development Advisory Group (EDAG) established the MassBio Leading Impact Award to annually recognize significant contributions made by individuals and organizations that have successfully worked to improve the competitiveness of Massachusetts as a destination for the life sciences industry. Past winners include the Massachusetts Biomedical Initiatives incubator and Pfizer’s Center for Therapeutic Innovation. Examples of potential honorees include municipal governments that have removed barriers to entry for life sciences facility projects, organizations that have advanced industry growth through unique civic engagement, or developers or individuals whose exemplary actions over time or on specific projects have contributed to the growth of the industry.
Nominations for the 2014 Leading Impact Award must be submitted by 5 p.m. on Feb. 21. The awardee(s) will be recognized at the MassBio Annual Meeting in April. Submitting a nomination is easy: Go to MassBio’s website at www.MassBio.org to find the submission link in the news section.